Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Choi

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Plos One|March 17, 2011
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitorsMaria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.
Journal of the American Geriatrics Society|January 17, 2017
Aging, the Medical Subspecialties, and Career Development: Where We Were, Where We Are GoingArti Hurria, Kevin P High, Lona Mody, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Breast Cancer Research : BCR|August 31, 2017
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 5, 2021
Enhanced Recovery After Cardiac Surgery: A Propensity-Matched AnalysisFarhang Yazdchi, Sameer Hirji, Morgan Harloff, et al.
Gastroenterology|June 10, 2015
MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in MiceChristos Polytarchou, Daniel W Hommes, Tiziana Palumbo, et al.
Clinical Breast Cancer|December 4, 2018
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and OncologyArti Hurria, Enrique Soto-Perez-de-Celis, Suzette Blanchard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2015
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapiesAlexandre Chan, Michael C Cameron, Benjamin Garden, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Plos One|March 17, 2011
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitorsMaria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.
Journal of the American Geriatrics Society|January 17, 2017
Aging, the Medical Subspecialties, and Career Development: Where We Were, Where We Are GoingArti Hurria, Kevin P High, Lona Mody, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Breast Cancer Research : BCR|August 31, 2017
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 5, 2021
Enhanced Recovery After Cardiac Surgery: A Propensity-Matched AnalysisFarhang Yazdchi, Sameer Hirji, Morgan Harloff, et al.
Gastroenterology|June 10, 2015
MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in MiceChristos Polytarchou, Daniel W Hommes, Tiziana Palumbo, et al.
Clinical Breast Cancer|December 4, 2018
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and OncologyArti Hurria, Enrique Soto-Perez-de-Celis, Suzette Blanchard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2015
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapiesAlexandre Chan, Michael C Cameron, Benjamin Garden, et al.
Pageof 8